Towards an HIV Cure
AIM: To drive concerted efforts to accelerate global scientific research, advocacy and collaboration towards a cure for HIV
"It is time to more firmly plant the need for an HIV cure on the policy agenda. While interventions that lead to a meaningful cure are at least decades away, we must begin planning for it sooner than later. Once available, we must ensure a cure can be successfully delivered to those countries most burdened by the disease, and delivery must come at speed."
Sharon Lewin
IAS Towards an HIV Cure Advisory Board Co-Chair
With support from:
Towards an HIV Cure Advisory Board
Towards an HIV Cure Advisory Board
- Charu Kaushic, Canadian Institute of Health Research (CIHR), Canada
- Diana Finzi, NIAID/NIH, USA
- Glaudina Loots, Department of Science & Innovation, South Africa
- Glenda Gray, South African Medical Research Council, South Africa
- Marcus Low, Treatment Action Campaign (TAC), South Africa
- Maureen Goodenow, NIH-OAR, USA
- Meg Doherty, WHO, Switzerland
- Michaela Muller-Trutwin, ANRS and Institut Pasteur, France
- Mike McCune, Bill & Melinda Gates Foundation, USA
- Mitchell Warren, AVAC, USA
- Moses Supercharger Nsubuga, Stigmaless, Uganda
- Peter Godfrey-Faussett, UNAIDS, Switzerland
- Remko van Leeuwen, Aidsfonds, The Netherlands
- Richard Jefferys, Treatment Action Group (TAG), USA
- Rowena Johnston, amfAR, USA
- Serawit Bruck Landais, Sidaction, France
- Sharon Lewin, The Doherty Institute, University of Melbourne, Australia
- Steve Deeks, UCSF, USA
- Thumbi Ndung’u, University of KwaZulu-Natal and Africa Health Research Institute, South Africa
- Yiming Shao, CDC, China